LONDON BROKER RATINGS: Goldman and UBS cut Legal & General to 'sell'
(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday: Read More
| Price | 1,638.00p on 11-08-2026 at 18:35:10 |
|---|---|
| Change | -11.00p -0.67% |
| Buy | 1,634.00p |
| Sell | 1,632.00p |
| Last Trade: | Buy 197.00 at 1,638.00p |
| Day's Volume: | 1,011,110 |
| Last Close: | 1,638.00p |
| Open: | 1,655.00p |
| ISIN: | GB00B0LCW083 |
| Day's Range | 1,618.00p - 1,655.00p |
| 52wk Range: | 1,187.00p - 1,865.00p |
| Market Capitalisation: | £3.40b |
| VWAP: | 1,635.07171p |
| Shares in Issue: | 207.79m |
Hikma Pharmaceuticals (HIK) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 197 | 1,638.00p | SI Trade Negotiated Trade |
16:53:47 - 11-Aug-26 |
| Buy* | 59,000 | 1,638.00p | Suspected BUY Trade |
16:39:19 - 11-Aug-26 |
| Sell* | 3,155 | 1,638.00p | Automatic Execution |
16:35:18 - 11-Aug-26 |
| Buy* | 25,811 | 1,638.00p | SI Trade |
16:35:17 - 11-Aug-26 |
| Buy* | 15,713 | 1,638.00p | SI Trade |
16:35:17 - 11-Aug-26 |
| Buy* | 17,476 | 1,638.00p | SI Trade |
16:35:17 - 11-Aug-26 |
| Sell* | 287,689 | 1,638.00p | Uncrossing Trade |
16:35:17 - 11-Aug-26 |
| Sell* | 114,438 | 1,634.1239p | Negotiated Trade |
16:32:59 - 11-Aug-26 |
| Sell* | 403 | 1,633.00p | Automatic Execution |
16:29:56 - 11-Aug-26 |
| Sell* | 143 | 1,633.00p | Automatic Execution |
16:29:56 - 11-Aug-26 |
Hikma Pharmaceuticals (HIK) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 10th Aug 2026 10:05 am | RNS | Transaction in Own Shares |
| 6th Aug 2026 7:01 am | RNS | Directorate change |
| 6th Aug 2026 7:00 am | RNS | Half-year Financial Report |
| 3rd Aug 2026 12:49 pm | RNS | Total Voting Rights |
| 3rd Aug 2026 10:19 am | RNS | Transaction in Own Shares |
| 28th Jul 2026 3:44 pm | RNS | Holding(s) in Company |
| 27th Jul 2026 11:48 am | RNS | Transaction in Own Shares |
| 24th Jul 2026 11:25 am | RNS | Holding(s) in Company |
| 23rd Jul 2026 3:21 pm | RNS | Holding(s) in Company |
| 20th Jul 2026 9:22 am | RNS | Transaction in Own Shares |